Structural modeling of p.V31F variant in the aspartoacylase gene

Metabolic Brain Disease
Navaneethakrishnan Krishnamoorthy, Hatem Zayed

Abstract

Aspartoacylase (ASPA) is an abundant enzyme in the brain, which catalyzes the conversion of N-acetylaspartate into acetate and aspartate, deficiency in its activity leads to degeneration of the white matter of the brain and is a recognized cause of Canavan disease (CD), which affect children. Although genotype-phenotype correlation have been reported for Canavan disease patients, this relationships is still not straightforward. In this communication, we use molecular modeling to address the structural consequences resulting from the missense variant p.V31F in the ASPA enzyme, which we previously reported in a homozygous form in an Egyptian patient with infantile CD. This modeling suggests that this variant brings significant changes to the catalytic core by introducing structural flexibility through neighbouring key residues. In particular, it provides a molecular explanation for the pathogenic effect of this variant and provides a meaningful genotype-phonotype relationships. The mutational impact appears to have an influence on the function of the protein and initiates molecular event for the mechanism of the disease.

References

Oct 1, 1995·The Journal of Pediatrics·R MatalonR Kaul
Jan 1, 1993·Journal of Inherited Metabolic Disease·R MatalonK Michals
Sep 24, 1999·Journal of Molecular Biology·K S Makarova, N V Grishin
Apr 23, 2003·Archives of Biochemistry and Biophysics·Roger A MooreRonald E Viola
Oct 22, 2003·Molecular Genetics and Metabolism·Sankar SurendranReuben Matalon
Dec 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Eduard BittoGeorge N Phillips
Mar 30, 2007·Brain Research·Jeremy R HershfieldM A Aryan Namboodiri
Mar 26, 2013·PloS One·Poornima GajendraraoMagdi H Yacoub
Feb 11, 2015·Gene·Hatem Zayed
Nov 29, 2015·Metabolic Brain Disease·Osama K ZakiHatem Zayed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Canavan Disease

Canavan disease, a type of leukodystrophy, is an autosomal recessive neurodegenerative disorder, and is one of the most common degenerative cerebral diseases of infancy. Discover the latest research on Canavan disease here.